About Fran Magee
Fran Magee is a chief technology officer at Spine BioPharma.
Fran Magee first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Fran Magee in the role, so the role may have started earlier or lasted longer.
Spine BioPharma, Inc.
Chief Technology Officer
2022 – 2026 · New York, NY
Develops non-opioid, non-surgical treatments for people with pain-related disabilities.
Key Colleagues at Startups
The people Fran Magee works with at each company, as listed on that company's latest Form D.
Spine BioPharma, Inc. · Form D, Jun 5, 2026
JV
John Viscogliosi
Director
TP
Thomas Bumol, PhD
Director
MV
Marc Viscogliosi
CEO and director
FM
Frank Cammisa, MD
Director